Regarding CTNNB1 exon 3, mutations were identified in 17.2% of HCC tissue samples, a frequency comparable to the 23.1% prevalence reported in a global series of 5276 HCC cases [10]. Here, CTNNB1 is linked to hepatocellular carcinoma.